Securities code: Joincare Pharmaceutical Group Industry Co.Ltd(600380) securities abbreviation: Joincare Pharmaceutical Group Industry Co.Ltd(600380) Announcement No.: pro 2022048 Joincare Pharmaceutical Group Industry Co.Ltd(600380)
Notice on convening the 2021 annual general meeting of shareholders
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents. Important content tips:
Date of shareholders’ meeting: May 18, 2022
The online voting system adopted for the general meeting of shareholders: the online voting system of the general meeting of shareholders of Shanghai Stock Exchange
1、 Basic information of the meeting
1. Type and session of general meeting of shareholders
2021 annual general meeting
2. Convener of general meeting of shareholders: Board of directors
3. Voting method: the voting method adopted at this shareholders’ meeting is a combination of on-site voting and online voting
4. Date, time and place of site meeting
Date and time: 14:00 on May 18, 2022
Venue: conference room 2, Joincare Pharmaceutical Group Industry Co.Ltd(600380) Pharmaceutical Group building, No. 17, Langshan Road, North District, high tech Zone, Nanshan District, Shenzhen 5. Online voting system, start and end date and voting time.
Online voting system: online voting system for shareholders’ meeting of Shanghai Stock Exchange
Starting and ending time of online voting: from May 18, 2022
To May 18, 2022
The online voting system of Shanghai Stock Exchange is adopted. The voting time through the trading system voting platform is the trading time period on the day of the general meeting of shareholders, i.e. 9:15-9:25, 9:30-11:30, 13:00-15:00; The voting time through the Internet voting platform is 9:15-15:00 on the day of the general meeting of shareholders.
6. Margin trading, refinancing, agreed repurchase business accounts and voting procedures for investors of Shanghai Stock connect
Accounts related to margin trading, refinancing business, agreed repurchase business and the voting of investors in Shanghai Stock connect shall be implemented in accordance with the relevant provisions of the guidelines for self discipline supervision of listed companies of Shanghai Stock Exchange No. 1 – standardized operation. 2、 Matters considered at the meeting
The types of proposals and voting shareholders deliberated at the general meeting of shareholders
Serial number proposal name voting shareholder type A-share shareholder
Non cumulative voting motion
1 work report of the board of supervisors in 2021 √
2 proposal on electing Mr. Xing Zhiwei as the supervisor of the company √
3 work report of the board of directors in 2021 √
4 financial statement report of 2021 √
5 profit distribution plan for 2021 √
6 Joincare Pharmaceutical Group Industry Co.Ltd(600380) 2021 annual report (full text and abstract) √
7. About reviewing the certificate of Joincare Pharmaceutical Group Industry Co.Ltd(600380) Pharmaceutical Group shares √ issued by Zhitong Certified Public Accountants (special general partnership)
Proposal on internal control audit report of limited company
About reviewing the collection of Joincare Pharmaceutical Group Industry Co.Ltd(600380) pharmaceutical industry issued by Zhitong Certified Public Accountants (special general partnership)
Special √ of the summary of non operating capital occupation and other related capital transactions of 8tuan Co., Ltd
Proposal on Audit Report
9 proposal on adjusting the allowance of independent directors of the company √
10 proposal on the company’s credit financing and providing financing guarantee for its subsidiaries √
11 proposal on the company and its holding subsidiary Jiaozuo Joincare Pharmaceutical Group Industry Co.Ltd(600380) providing guarantee for Jinguan power loan √
12 “on renewing the appointment of Zhitong Certified Public Accountants (special general partnership) as the accountant of annual audit in 2022 √
Proposal of the Office
13. About the company’s second phase of shareholding plan for medium and long term business partners (Draft) and its √
Abstract proposal
14 √ on requesting the general meeting of shareholders to authorize the board of directors to handle the shareholding plan of the company’s medium and long-term business partners
Proposal on matters related to phase II shareholding plan
In addition: listen to the work report of independent directors in 2021
1. Time and media of disclosure of each proposal
The above-mentioned proposal 1 has been deliberated and adopted at the 8th meeting of the 8th board of supervisors of the company. For details, the company published it on China Securities News, Shanghai Securities News, securities times, securities daily and the website of Shanghai Stock Exchange (www.sse. Com. CN) on March 31, 2022 Announcement on the resolutions of the 8th meeting of the Joincare Pharmaceutical Group Industry Co.Ltd(600380) 8th board of supervisors (p.2022025) publicly disclosed;
The above-mentioned proposal 2 has been deliberated and adopted at the 9th meeting of the 8th board of supervisors of the company. For details, the company published it on China Securities News, Shanghai Securities News, securities times, securities daily and the website of Shanghai Stock Exchange (www.sse. Com. CN) on April 25, 2022 Public announcement on the resolutions of the 9th meeting of the Joincare Pharmaceutical Group Industry Co.Ltd(600380) 8th board of supervisors (p.2022045);
The above proposals 3 to 12 have been deliberated and adopted at the 9th meeting of the 8th board of directors of the company. For details, the company published them on China Securities Journal, Shanghai Securities News, securities times, securities daily and the website of Shanghai Stock Exchange (www.sse. Com. CN) on March 31, 2022 Announcement on the resolutions of the 9th meeting of the Joincare Pharmaceutical Group Industry Co.Ltd(600380) 8th board of directors (p.2022026) publicly disclosed;
The above-mentioned proposals 13 to 14 have been deliberated and adopted at the 10th meeting of the eighth board of directors of the company. For details, the company published them on China Securities News, Shanghai Securities News, securities times, securities daily and the website of Shanghai Stock Exchange (www.sse. Com. CN) on April 25, 2022 Announcement on the resolutions of the 10th meeting of the Joincare Pharmaceutical Group Industry Co.Ltd(600380) 8th board of directors (p.2022047) publicly disclosed.
2. Special resolution proposal: the above proposals 5, 10 and 11 are special proposals, which shall be approved by more than two-thirds of the voting rights held by the shareholders (including shareholders’ agents) attending the general meeting of shareholders.
3. Proposal on separate vote counting for small and medium-sized investors: the above proposals 2, 4, 5, 9 to 14 require separate vote counting for small and medium-sized investors of the company.
3、 Precautions for voting at the general meeting of shareholders
1. If the shareholders of the company exercise their voting rights through the online voting system of the general meeting of shareholders of Shanghai Stock Exchange, they can either log in to the voting platform of the trading system (through the trading terminal of the securities company designated for trading) or log in to the Internet voting platform (website: vote. Sseinfo. Com) Vote. For the first time to log in to the Internet voting platform to vote, investors need to complete shareholder identity authentication. Please refer to the instructions on the website of the Internet voting platform for specific operations. 2. Shareholders exercise their voting rights through the online voting system of the general meeting of shareholders of Shanghai Stock Exchange. If they have multiple shareholder accounts, they can use any shareholder account holding the company’s shares to participate in online voting. After voting, it shall be deemed that all ordinary shares of the same class or preferred shares of the same variety under their shareholder accounts have voted for the same opinion respectively.
3. If the same voting right is voted repeatedly through on-site, online voting platform of the exchange or other means, the first voting result shall prevail.
4. Shareholders can submit all proposals only after voting.
4、 Meeting attendees
1. After the closing of the stock market on the equity registration date, the shareholders of the company registered in Shanghai Branch of China Securities Depository and Clearing Co., Ltd. have the right to attend the general meeting of shareholders (see the table below for details), and can entrust agents to attend the meeting and vote in writing. The proxy need not be a member of the company.
Stock category Stock Code Stock abbreviation equity registration date
A-share Joincare Pharmaceutical Group Industry Co.Ltd(600380) Joincare Pharmaceutical Group Industry Co.Ltd(600380) 2022 / 5 / 11
2. Directors, supervisors and senior managers of the company.
3. A lawyer employed by the company.
4. Other personnel
5、 Meeting registration method
1. Registration and attendance certificate of on-site meeting: natural person shareholders register and attend the meeting with their own ID card and securities account card; If the legal representative attends the meeting, the legal person shareholder shall register and attend the meeting with the legal person’s securities account card, a copy of the business license stamped with the official seal, and the legal representative’s own ID card (or identity certificate). If another person is entrusted to attend the meeting, the agent shall register and attend the meeting with his ID card, the written power of attorney issued by the corresponding person according to law (see the annex for details) and the above-mentioned corresponding certificates;
2. Registration method: the shareholders or agents of the company can register directly at the company or by fax or letter (subject to the fax or letter received by the company before 17:00 on Tuesday, May 17, 2022). The registration time of on-site meeting: 9:30-11:00 and 13:00-14:00 on Wednesday, May 18, 2022. 3. Registration place: Board Office of Joincare Pharmaceutical Group Industry Co.Ltd(600380) Pharmaceutical Group building, No. 17, Langshan Road, North District, high tech Zone, Nanshan District, Shenzhen.
6、 Other matters
1. Meeting contact: Office of the board of directors
2. Tel: 075586252656
3. Fax: 075586252165
4. Email: [email protected].
5. The on-site meeting of the general meeting of shareholders lasts for half a day, and the participants shall bear their own accommodation and transportation expenses.
It is hereby announced.
Joincare Pharmaceutical Group Industry Co.Ltd(600380) April 25, 2022 Annex I
Joincare Pharmaceutical Group Industry Co.Ltd(600380)
Power of attorney for 2021 annual general meeting
Joincare Pharmaceutical Group Industry Co.Ltd(600380) ：
I hereby entrust Mr. (Ms.) to attend the 2021 annual general meeting of shareholders of your company held on May 18, 2022 on behalf of my unit (or myself) and exercise voting rights on behalf of me. Number of ordinary shares held by the trustor: account number of the trustor’s shareholder:
No. name of non cumulative voting proposal agree against abstain
1 work report of the board of supervisors in 2021 2 proposal on electing Mr. Xing Zhiwei as the supervisor of the company 3 work report of the board of directors in 2021 4 final financial statement report in 2021 5 profit distribution plan in 2021
6 Joincare Pharmaceutical Group Industry Co.Ltd(600380) 2021 annual report (full text and abstract)
7. About reviewing the certificate of Joincare Pharmaceutical Group Industry Co.Ltd(600380) issued by Zhitong Certified Public Accountants (special general partnership)
Proposal on “audit report on internal control” of Industrial Group Co., Ltd
About reviewing the “about health” issued by Zhitong Certified Public Accountants (special general partnership)
8. Occupation of non operating funds and other related funds of Kangyuan Pharmaceutical Group Co., Ltd
Proposal on the special audit report of the summary of current situation
9 proposal on adjusting the allowance of independent directors of the company 10 proposal on the company’s credit financing and providing financing guarantee for its subsidiaries 11 proposal on the company and its holding subsidiary Jiaozuo Joincare Pharmaceutical Group Industry Co.Ltd(600380) providing guarantee for Jinguan power loan
Proposal for
12 “about renewing the appointment of Zhitong Certified Public Accountants (special general partnership) for the annual review in 2022”
Proposal of accounting firm
13. The second phase shareholding plan of the company’s medium and long term business partner shareholding plan (Draft)
(proposal) and its summary
14. Proposal for the general meeting of shareholders to authorize the board of directors to handle the shareholding of medium and long-term business partners of the company
Proposal on matters related to the second phase of the plan
Signature (seal) of the trustor: signature of the trustee:
The ID number of the client: the ID number of the trustee:
